Search results
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena· 35 minutes agoNucala was the first interleukin-5 (IL-5) inhibitor to be approved for marketing, getting a nod from...
Nucala was the first interleukin-5 (IL-5) inhibitor to be approved for marketing, getting a nod from...